Cannabinoids in Pediatric Care: Evidence-Based Clinical Review
Cannabinoid use in children is an evolving area with limited rigorous evidence. Most data comes from observational studies rather than controlled trials. This review highlights the current clinical evidence and safety considerations for cannabinoids in…
Use of Medical Marijuana or Hemp Doesn’t Excuse Drug Testing Violations
2026 cannabis federal workplace regulations clarify that medical marijuana or hemp use does not exempt employees from drug testing violations. Patients using medical cannabis may still face employment consequences despite state legalization. Clinicians…
Congressional Debate on Hemp THC Regulation and Farm Bill
The recent farm bill highlights hemp THC regulation challenges amid ongoing federal uncertainty. Hemp-derived THC products remain in a complex legal gray area. Clinicians face difficulties counseling patients due to shifting hemp THC policies.
CED Cannabis Research Digest — February 27, 2026
The cannabis medicine research digest for February 27, 2026, highlights key peer-reviewed studies scored for clinical relevance. This weekly digest provides a curated summary of cannabis research to inform patient care. Stay updated with the latest…
Substance Use on the Rise Among Gen Z in Their Early 20s | UCL News
Rising substance use in young adults is a significant trend among Gen Z in their early twenties. Clinicians must understand these patterns to screen and identify at-risk populations effectively. Early intervention can help address substance use and…
The Wait is Over: Medical Cannabis Set to Roll Out in Alabama in April
Alabama medical cannabis program is moving forward with an official rollout planned for April. This program will expand patient access to cannabis therapeutics under state regulations. Physicians should prepare to integrate Alabama medical cannabis…
Ricketts Addresses Nebraska’s Exclusion from Federal Medical Cannabis Protections
Nebraska medical cannabis laws face challenges due to lack of federal protection, creating legal uncertainty for clinicians and patients. This gap affects prescribing practices and patient access to cannabis treatments. Understanding Nebraska medical…
GLP-1 Medications Get at the Heart of Addiction, Study Finds
GLP-1 medications addiction treatment shows promise in reducing cannabis use disorder alongside other substance use disorders. These medications may address multiple addiction pathways simultaneously rather than targeting individual substances.…
Campaign Launched in Memory of Mum Who Helped Change UK Medical Cannabis Law
NHS access barriers medical cannabis remain a critical issue for pediatric drug-resistant epilepsy patients in the UK. Despite legal changes, many children cannot access cannabinoid therapies through the NHS. This campaign highlights the urgent need for…
Washington Senators Approve Bill To Let Terminally Ill Patients Use Medical Cannabis In Hospitals
Washington state legislation now permits medical cannabis use in hospitals for terminally ill patients. This policy change supports symptom management in inpatient settings with proper authorization. Medical cannabis use in hospitals offers new options…